Testing novel genetic therapies for ACTA1 nemaline myopathy (NEM3) – harnessing patient cells

Project Details

StatusFinished
Effective start/end date5/08/204/08/22

Funding

  • A Foundation Building Strength Inc: A$52,118.00
  • A Foundation Building Strength Inc: A$119,932.00
  • A Foundation Building Strength Inc: A$64,334.00